https://www.pharmaceutical-technology.com/data-insights/cadisegliatin-vtv-therapeutics-type-1-diabetes-juvenile-diabetes-likelihood-of-approval/
Cadisegliatin is under clinical development by vTv Therapeutics and currently in Phase III for Type 1 Diabetes (Juvenile Diabetes).
cadisegliatinvtvtherapeuticstypediabetes